Residual SYNTAX II Score and long-term outcomes post-ST-elevation myocardial infarction in an urban US cohort: the Montefiore STEMI Registry.

Background: Higher residual anatomic disease was associated with increased mortality in a recent randomized controlled trial of revascularization after ST-elevation myocardial infarction (STEMI). Less is known about the impact of residual disease post-STEMI in race-ethnic minorities.

Methods: Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX)- II (SS-II) score is an established scoring method for anatomic disease and prevalent co-morbidities to describe patient complexity.

Cancer Survivorship, Models, and Care Plans: A Status Update.

This article provides a synopsis of the status of cancer survivorship in the United States. It highlights the challenges of survivorship care as the number of cancer survivors has steadily grown over the 40 years since the signing of the National Cancer Act in 1971. Also included is an overview of various models of survivorship care plans (SCPs), facilitators and barriers to SCP use, their impact on patient outcomes, and implications for clinical practice and research.